Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

SINGAPORE, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 1276

Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Malaysia

KUALA LUMPUR, Malaysia, March 10, 2022 /PRNewswire/ -- Baxter Malaysia, a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 5099

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

- Cystinosis is a rare genetic disease affecting 1 in 100,000-200,000 live births and poses a lifelong risk to those affected. Cystinosis slowly destroys the body's organs including the kidneys, eyes, thyroid, muscles, liver, pancreas, gonads, and brain. - There are currently no curative treatme...

2022-03-10 00:57 2097

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin

Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...

2022-03-09 23:20 1823

Databricks Introduces Lakehouse for the Healthcare and Life Sciences Industries to Drive Transformation Across Healthcare Ecosystem

As the industry begins to embrace the power of AI, the lakehouse brings patient, research, and operational data together at scale to deliver new innovations in research and care SAN FRANCISCO, March 9, 2022 /PRNewswire/ -- Databricks, the Data and AI company and pioneer of the data lakehouse par...

2022-03-09 22:00 1720

SOPHiA GENETICS HRD Solution Adopted in Asia Pacific

BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...

2022-03-09 21:57 1948

NCCN Expands Resources for Treating Rare Cancer Types

The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templat...

2022-03-09 21:56 1417

NCCN Expands Resources for Treating Rare Cancer Types

English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022.

TOKYO, March 9, 2022 /PRNewswire/ -- Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter "Jolly Good"), known for developing and providing medical VR solutions and digital therapeutics VR programs, has developed an English version of their VR medical hands-on tracking ...

2022-03-09 21:00 1295

English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022.

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that two poster presentations featuring translational r...

2022-03-09 21:00 1522

Kusum Healthcare recognized as one of Best Places to Work in Philippines for 2022

MANILA, Philippines, March 9, 2022 /PRNewswire/ -- Kusum Healthcare, a leading tech-driven pharmaceutical group, has been recently awarded the Best Place to Work certification inPhilippines for 2022. During the company assessment, 97% of employees recommended the organization illustrating the com...

2022-03-09 20:22 1601

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 2177

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

The firm once again participates in the fight against the pandemic by donating robots that support contactless delivery and automatic disinfection SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics , the global leader in commercial service robots, has dona...

2022-03-09 20:00 2325

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

- XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. - XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option. ...

2022-03-09 19:08 2121

Cappfinity and Lexxic partnership helps organisations embrace neurodiversity in the workplace

LONDON, March 9, 2022 /PRNewswire/ -- HR tech firm, Cappfinity, has announced a new partnership with specialist neurodiversity consultancy, Lexxic, to help businesses create a culture that enables neurodivergent talent to flourish. Operating since 2007, Lexxic was founded by Chartered Occupationa...

2022-03-09 16:55 1498

Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting

* New IND-enabling programs reinforce commitment to build a deep, broad and differentiated pipeline that transforms cancer immunotherapy leveraging company's AI-powered platform - * SAFEbody® precision masking technology integrated across antibody-based modalities in POWERbody® candidates, de...

2022-03-09 10:21 2550

Alphamab Oncology to Present Clinical Data of KN026 Combined with KN046 in HER2-positive Solid Tumors at AACR 2022

SUZHOU, China, March 9, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase II clinical study (KN026-203) of KN026 (HER2 bispecific antibody) combined with KN046 (PD-L1/CTLA-4 bispecific antibody) will be presented by E- poster at the 113th American Associa...

2022-03-09 09:14 1978

Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022

SUZHOU, China and ROCKVILLE, Md., March 8, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the results from six preclinical studies of t...

2022-03-09 07:47 3171

ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer

SEATTLE, Wash. and SUZHOU, China, March 8, 2022 /PRNewswire/ -- ProfoundBio announced that preclinical data from its pipeline of novel, proprietary antibody-drug conjugates (ADCs) and technology will be presented at the American Association for Cancer Research (AACR) Annual Meeting being held Apr...

2022-03-09 06:58 4214

Omega Healthcare Acquires Reventics, a Physician Focused CDI and RCM Company

BOCA RATON, Fla., March 9, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, today announced its acquisition of Reventics, aDenver, CO based company. Reventics is a clinical documentation improvement ("CDI") and re...

2022-03-09 06:38 1489

FIRST SURGERIES COMPLETED WITH PATIENT-SPECIFIC 3D PRINTED IMPLANTS PRODUCED AT THE LIMACORPORATE PROMADE POINT OF CARE CENTER AT HOSPITAL FOR SPECIAL SURGERY

UDINE, Italy, March 9, 2022 /PRNewswire/ -- LimaCorporate S.p.A., leading global orthopedics manufacturer, and Hospital for Special Surgery (HSS), consistently ranked number one in orthopedics globally by Newsweek and nationally byU.S. News & World Report in the U.S., today announced a new miles...

2022-03-09 06:16 1644

1 ... 274 275 276277278 279 280 ... 577